Cefazolin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0143-9923 -
Package NDC
0143-9923-90 -
Application number
ANDA065047 -
SPL ID
6cdaf80f-9ba2-4b0f-903d-61e0811ffaae -
SPL set ID
1dc9de56-e259-4546-a1db-23119a8a088e -
UNII
P380M0454Z -
RxCUI
1665050 -
RxCUI
1665052
What the source publishes
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Active ingredients
- Cefazolin
- Form
- INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cefazolin",
"splId": "6cdaf80f-9ba2-4b0f-903d-61e0811ffaae",
"labels": [
{
"setId": "1dc9de56-e259-4546-a1db-23119a8a088e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1dc9de56-e259-4546-a1db-23119a8a088e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1dc9de56-e259-4546-a1db-23119a8a088e"
}
],
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS"
],
"labeler": "Hikma Pharmaceuticals USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2.2 mL in 1 VIAL (0143-9923-90)",
"package_ndc": "0143-9923-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20010918"
}
],
"productId": "0143-9923_6cdaf80f-9ba2-4b0f-903d-61e0811ffaae",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, FOR SOLUTION",
"productNdc": "0143-9923",
"deaSchedule": null,
"genericName": "Cefazolin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CEFAZOLIN SODIUM",
"strength": "225 mg/mL"
}
],
"applicationNumber": "ANDA065047",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20010918",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"P380M0454Z"
],
"rxcui": [
"1665050",
"1665052"
],
"spl_set_id": [
"1dc9de56-e259-4546-a1db-23119a8a088e"
],
"manufacturer_name": [
"Hikma Pharmaceuticals USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0143-9923_6cdaf80f-9ba2-4b0f-903d-61e0811ffaae"